Document Detail

Gemigliptin, a novel dipeptidyl peptidase-4 inhibitor, exhibits potent anti-glycation properties in vitro and in vivo.
MedLine Citation:
PMID:  25448307     Owner:  NLM     Status:  Publisher    
This study evaluated the inhibitory effects of gemigliptin, a highly selective dipeptidyl peptidase-4 inhibitor, on the formation of advanced glycation end products (AGEs) and AGE cross-links with proteins in in vitro as well as in type 2 diabetic db/db mice. In in vitro assay, gemigliptin dose-dependently inhibited methylglyoxal-modified AGE-bovine serum albumin (BSA) formation (IC50=11.69mM). AGE-collagen cross-linking assays showed that gemigliptin had a potent inhibitory effect (IC50=1.39mM) on AGE-BSA cross-links to rat tail tendon collagen, and its activity was stronger than aminoguanidine (IC50=26.4mM). In addition, gemigliptin directly trapped methylglyoxal in a concentration-dependent manner in vitro. To determine whether gemigliptin inhibits the in vivo glycation processes, gemigliptin (100mg/kg/day) was orally administered into type 2 diabetic db/db mice for 12 weeks. Elevated serum levels of AGEs in db/db mice were suppressed by the administration of gemigliptin. These inhibitory effects of gemigliptin on the glycation process in both in vitro and in vivo suggest its therapeutic potential for ameliorating AGE-related diabetic complications.
Eunsoo Jung; Junghyun Kim; Sung Ho Kim; Sanghwa Kim; Myung-Haing Cho
Related Documents :
15592137 - The alzheimer's disease assessment scale-cognitive subscale: normative data for older a...
17936377 - An adaptation of the korean mini-mental state examination (k-mmse) in elderly koreans: ...
24989767 - Acantholachesilla gen. n. (psocodea:'psocoptera': lachesillidae: eolachesillinae: graph...
17503237 - Normative values for the assessment of gustatory function using liquid tastants.
16887727 - Effects of weight, age, and time on artemether-lumefantrine associated ototoxicity and ...
7650137 - Combined effects of maternal age and delayed fertilization on the frequency of chromoso...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-10-18
Journal Detail:
Title:  European journal of pharmacology     Volume:  744C     ISSN:  1879-0712     ISO Abbreviation:  Eur. J. Pharmacol.     Publication Date:  2014 Oct 
Date Detail:
Created Date:  2014-12-2     Completed Date:  -     Revised Date:  2014-12-3    
Medline Journal Info:
Nlm Unique ID:  1254354     Medline TA:  Eur J Pharmacol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  98-102     Citation Subset:  -    
Copyright Information:
Copyright © 2014 Elsevier B.V. All rights reserved.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The kallikrein system in retinal damage/protection.
Next Document:  Berberine alters epigenetic modifications, disrupts microtubule network, and modulates HPV-18 E6-E7 ...